SABRA HEALTH CARE REIT, INC. (SBRA)

Import this data to Google Sheets with:

=jivedata("SBRA","financials")

Full statements spill as a table. For one cell: =jivedata("SBRA","Revenue") or =jivedata("SBRA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

SABRA HEALTH CARE REIT, INC.

SBRA • CIK 0001492298

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	$18,655	$128,114	$153,419	$60,346
Income Tax Expense (Benefit)	$2,002	$1,005	$1,837	$2,131
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	—	$155,510	$65,229
Net Income (Loss) Attributable to Noncontrolling Interest	—	—	$-99	$-212
Net Income (Loss) Attributable to Parent	$13,756	$126,712	$155,609	$65,441
Weighted Average Number of Shares Outstanding, Basic	231,203,391	233,498,736	241,312,309	255,580,789
Weighted Average Number of Shares Outstanding, Diluted	232,792,778	236,045,862	244,497,242	259,541,352
Operating Lease, Lease Income	$376,266	$381,495	$374,131	$374,629
Revenue from Contract with Customer, Excluding Assessed Tax	$236,153	$284,581	$356,883	$445,938
Interest and Fee Income, Loans and Leases	$35,095	$37,159	$43,618	$38,991
Revenues	$647,514	$703,235	$774,632	$859,558
Depreciation, Depletion and Amortization	$183,087	$169,623	$186,996	$209,426
Interest Expense, Debt	$112,964	$115,272	$112,489	$116,029
General and Administrative Expense	$47,472	$50,067	$53,710	$60,149
Accounts Receivable, Credit Loss Expense (Reversal)	$191	$-571	$-1,047	$101,585
Impairment of Real Estate	$14,332	$18,472	$7,322	$3,659
Gain (Loss) on Extinguishment of Debt	$-1,541	$0	$-1,154	$-1,154
Other Operating Income (Expense), Net	$2,598	$2,735	$14,036	$-3,449
Gains (Losses) on Sales of Investment Real Estate	$-76,625	$2,095	$-3,519	$24,224
Other Nonoperating Income (Expense)	$-75,568	$4,830	$9,363	$19,621
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	1,589,387	2,446,335	2,871,902	2,724,330

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Real Estate Investment Property, Net	$4,617,261	$4,513,734	$4,686,377	$4,832,255
Equity Method Investments	$136,843	$121,803	$118,166	$113,889
Cash and Cash Equivalents, at Carrying Value	$41,285	$60,468	$71,537	$231,584
Restricted Cash and Cash Equivalents	$5,434	$5,871	$6,603	$6,756
Liabilities and Equity	$5,386,150	$5,303,679	$5,493,396	$5,512,610
Finite-Lived Intangible Assets, Net	$30,897	$27,464	$65,321	$82,953
Secured Debt	$47,301	$45,316	$43,275	$42,233
Long-term Line of Credit	$94,429	$106,554	$217,584	$317,475
Loans Payable to Bank	$537,120	$529,753	$1,032,311	$1,029,516
Unsecured Debt	$1,735,253	$1,736,025	$1,235,726	$1,236,940
Accounts Payable and Accrued Liabilities	$136,981	$117,896	$119,329	$114,953
Below Market Lease, Net	$32,532	$26,847	$21,383	$19,053
Liabilities	$2,583,616	$2,562,391	$2,669,608	$2,760,170
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$2,313	$2,376	$2,517	$2,555
Additional Paid in Capital	$4,494,755	$4,592,605	$4,836,270	$4,893,653
Accumulated Distributions in Excess of Net Income	$1,718,279	$1,874,633	$2,013,375	$2,151,582
Accumulated Other Comprehensive Income (Loss), Net of Tax	$23,745	$20,940	$-3,571	$6,097
Stockholders' Equity Attributable to Parent	$2,802,534	$2,741,288	$2,821,841	$2,750,723
Stockholders' Equity Attributable to Noncontrolling Interest	—	—	$1,947	$1,717
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	—	—	$2,823,788	$2,752,440
Real Estate Investment Property, Accumulated Depreciation	$1,021,086	$1,102,030	$1,224,663	$1,297,557
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Issued	231,266,020	237,586,882	251,697,456	255,462,756

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	—	$155,510	$65,229
Net Cash Provided by (Used in) Operating Activities	$300,571	$310,541	$348,613	$371,573
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$-6,599	$19,979	$11,410	$136,613
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-614	$-359	$391	$75
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$46,719	$66,339	$78,140	$172,694
Depreciation, Depletion and Amortization	$183,087	$169,623	$186,996	$209,426
Payments to Acquire Real Estate	$78,530	$136,430	$452,933	$684,325
Payments to Acquire Notes Receivable	$11,418	$21,645	$6,910	$4,794
Other Noncash Income (Expense)	$372	$-29	$-7	$-1
Amortization of Debt Issuance Costs and Discounts	$12,265	$10,479	$7,970	$9,253
Payments to Acquire Furniture and Fixtures	$84,855	$54,712	$41,521	$53,112
Share-based Payment Arrangement, Noncash Expense	$7,917	$8,987	$11,360	$13,132
Proceeds from Collection of Notes Receivable	$9,274	$3,551	$20,671	$218,704
Gain (Loss) on Extinguishment of Debt	$-1,541	$0	$-1,154	$-1,154
Accounts Receivable, Credit Loss Expense (Reversal)	$191	$-571	$-1,047	$101,585
Payments to Acquire Interest in Joint Venture	$5,235	$1,258	$1,241	$0
Gains (Losses) on Sales of Investment Real Estate	$-76,625	$2,095	$-3,519	$24,224
Proceeds from Sale of Other Productive Assets	$247,622	$95,999	$88,637	$178,665
Impairment of Real Estate	$14,332	$18,472	$7,322	$3,659
Proceeds from Lease Payment, Sales-Type and Direct Financing Leases, Investing Activity	$25,490	$0	$0	$0
Income (Loss) from Equity Method Investments	$-2,897	$-397	$3,928	$7,014
Proceeds from Hedge, Investing Activities	—	—	$4,462	$0
Proceeds from Equity Method Investment, Distribution	$3,469	$5,447	$7,813	$8,011
Proceeds from Insurance Settlement, Investing Activities	$5,801	$2,382	$1,589	$687
Other Operating Activities, Cash Flow Statement	$-3,704	$-534	$-17,190	$0
Proceeds from Equity Method Investment, Distribution, Return of Capital	$544	$0	$6,762	$6,762
Net Cash Provided by (Used in) Investing Activities	$103,130	$-109,001	$-377,960	$-334,972
Proceeds from (Repayments of) Lines of Credit	$-104,338	$14,595	$109,805	$155,461
Repayments of Unsecured Debt	$0	—	$500,000	$500,000
Proceeds from Issuance of Medium-term Notes	$12,188	$0	$500,000	$500,000
Repayments of Secured Debt	$1,979	$2,033	$2,089	$2,117
Payments of Financing Costs	$18,142	$94	$4,405	$4,417
Payment for Debt Extinguishment or Debt Prepayment Cost	$0	—	$2,884	$2,884
Proceeds from Noncontrolling Interests	—	—	$2,046	$2,048
Payment for Contingent Consideration Liability, Financing Activities	$17,900	$0	$0	$1,178
Payments of Dividends	$277,447	$280,150	$289,497	$298,057
Net Cash Provided by (Used in) Financing Activities	$-410,300	$-181,561	$40,757	$100,012
Interest Paid, Excluding Capitalized Interest, Operating Activities	$102,409	$105,200	$110,957	$114,985
Income Taxes Paid	$1,670	$1,389	$1,496	$1,496
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)	$4,644	$0	$0	$16,600
Increase (Decrease) in Prepaid Expense and Other Assets	$11,078	$15,462	$11,449	$16,504
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$8,344	$-7,087	$1,596	$7,807

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("SBRA","financials")

Full statements spill as a table. For one cell: =jivedata("SBRA","Revenue") or =jivedata("SBRA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.